Mitogen-Activated Protein Kinase 7 (MAPK7) (pThr218, pTyr220) antibody
| Antigen | Mitogen-Activated Protein Kinase 7 (MAPK7) |
| Synonyms | BMK1, ERK4, ERK5, PRKM7, Erk5-T, ATMPK7, F8D23.5, F8D23_5, MAP kinase 7, MPK7 |
| Binding Site |
Alternatives pThr218, pTyr220 |
| Clonality | Polyclonal |
| Host |
Alternatives Rabbit |
| Reactivity |
Alternatives Human |
| Conjugate |
Alternatives Un-conjugated |
| Application |
Alternatives Dot Blot (Dot), ELISA |
![]() |
2 references available |
| Certificates | ISO 9001:2008 |
| Catalog no. | ABIN389992 |
| Quantity | 400 µL (0.25 mg/ml) |
| Price | 280.50 $ Plus shipping costs $45.00 |
| Shipping to |
|
| Availability | Will be delivered in 2 to 3 Business Days |
Additional Information
| Alternative name | ERK5 |
| Gene ID | 5598 |
| UniProt | Q13164 |
| Immunogen | This Bi-phospho-ERK5-pT218/pY220 antibody is generated from rabbits immunized with a KLH conjugated synthetic phosphopeptide between 206~236 amino acids surrounding phosphorylated T218 and Y220 of human ERK5. |
| Isotype | Ig |
| Description | Other names: Extracellular signal-regulated kinase 5, Mitogen-activated protein kinase 7 |
| Characteristics | Peptide Affinity Purified Rabbit Polyclonal Antibody (Pab) |
| Specificity | This Bi-phospho-ERK5-pT218/pY220 antibody is generated from rabbits immunized with a KLH conjugated synthetic phosphopeptide between 206~236 amino acids surrounding phosphorylated T218 and Y220 of human ERK5. |
| Molecular Weight | 88636 DA |
| Comments |
Background: MEK5 and ERK5, a member of the MAP kinase subfamily of the Ser/Thr protein kinases, interact specifically with one another and not with MEK1/ERK1 or MEK2/ERK2 pathways. ERK5 is activated by tyrosine and threonine phosphorylation It is expressed in many adult tissues, abundantly in heart, placenta, lung, kidney and skeletal muscle, but is not detectable in liver. The second proline-rich region may interact with actin targeting the kinase to a specific location in the cell. ERK5 is autophosphorylated on threonine and tyrosine residues when the C-terminal part of the kinase, which could have a regulatory role, is absent. |
Application Details
| Application Notes | The suggested dilution is: ELISA ~~ 1:1,000 Dot Blot ~~ 1:500 |
| Concentration | 0.25 mg/ml |
| Purification | Purified |
| Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by two-step 2-sites phosphospecific peptide affinity purification. |
| Storage | Maintain refrigerated at 2-8 deg C for up to 6 months. For long term storage store at -20 deg C in small aliquots to prevent freeze-thaw cycles |
| Research Area | Phospho-specific antibodies, Cell Signaling, Protein Modifications, Cell Structure |
| Restrictions | For Research Use only |
Images
Publications
| Product |
Lee, Ulevitch, Han: "Primary structure of BMK1: a new mammalian map kinase." in: Biochemical and biophysical research communications, Vol. 213, Issue 2, pp. 715-24, 1995 (PubMed).
Zhou, Bao, Dixon: "Components of a new human protein kinase signal transduction pathway." in: The Journal of biological chemistry, Vol. 270, Issue 21, pp. 12665-9, 1995 (PubMed). |
Alternatives
Alternatives for antigen "Mitogen-Activated Protein Kinase 7 (MAPK7)", type "Antibodies"




Alternatives